Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03958006 · ClinicalTrials.gov registry record · NA
Simultaneous Cochlear Implantation During Translabyrinthine Resection of Vestibular Schwannoma
A NA study, sponsored by Henry Ford Health System.
- Completed
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT03958006: Completed NA study, sponsored by Henry Ford Health System.
NCT03958006 is a NA study that has completed, run by Henry Ford Health System. The registered enrollment target is 6 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03958006, a NA study, has completed, sponsored by Henry Ford Health System.
- COMPLETED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
This study will address the feasibility of simultaneous cochlear implantation during resection of a vestibular schwannoma.
Primary Outcome
Audiologist assesses changes in understanding of the AzBio test (words in quiet and words in background noise) post cochlear implantation.
Interventions
- DEVICE Cochlear implant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2018-12-05 |
| Est. Completion | 2023-01-30 |
| Phase | NA |
What the finished NCT03958006 record still lists
NCT03958006 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Cochlear implant is the first listed.
NCT03958006 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03958006 about?
NCT03958006 is a clinical study titled "Simultaneous Cochlear Implantation During Translabyrinthine Resection of Vestibular Schwannoma". This study will address the feasibility of simultaneous cochlear implantation during resection of a vestibular schwannoma.
What is the current status of trial NCT03958006?
This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2018-12-05. Estimated completion is 2023-01-30.
What interventions are being tested in trial NCT03958006?
The interventions under investigation include: Cochlear implant (DEVICE).
Who is sponsoring clinical trial NCT03958006?
This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03958006's enrollment target sits among peer trials
6 1983rd of 2000 higher than 13 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI